Relationship and factors responsible for regulating fasting and post-challenge plasma glucose levels in the early stage development of type 2 diabetes mellitus

Journal of Diabetes Investigation

Volumn 5, Issue 6, 2014, Pages 663-670

  Aoyama Sasabe, Sae ^a   Xin, Xin ^a   Taniguchi, Ataru ^b   Nakai, Yoshikatsu ^c   Mitsui, Rie ^d   Tsuji, Hideaki ^a   Yabe, Daisuke ^e   Yasuda, Koichiro ^f   Kurose, Takeshi ^e   Inagaki, Nobuya ^g   Seino, Yutaka ^e   Fukushima, Mitsuo ^a  

^a OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

^b Kyoto Preventive Medical Center   (Japan)

^c Kyoto Institute of Health Sciences   (Japan)

^d ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^e KANSAI ELECTRIC POWER CO   (Japan)

^f Saiseikai Noe Hospital   (Japan)

^g KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Fasting plasma glucose; Post challenge plasma glucose; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; DISEASE ASSOCIATION; DISEASE COURSE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84911104962     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12239     Document Type: Article

References (33)

1. Hanefeld M, Koehler C, Fuecker K, et al.; Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2003; 26: 868-874.
2. Weyer C, Bogardus C, Pratley RE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 1999; 48: 2197-2203.
3. DECODE Study Group, the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397-405.
4. Tominaga M, Eguchi H, Manaka H, et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 1999; 22: 920-924.
5. Nakagami T, DECODA study Group. Hyperglycemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 2004; 47: 385-394.
6. Ning F, Tuomilehto J, Pyörälä K, et al.; DECODE Study Group. Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range. Diabetes Care 2010; 33: 2211-2216.
7. Qiao Q, Hu G, Tuomilehto J, et al. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003; 26: 1770-1780.
8. The DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003; 26: 61-69.
9. Meyer C, Pimenta W, Woerle HJ, et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 2006; 29: 1909-1914.
10. Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance. Implications for care. Diabetes Care 2007; 30: 753-759.
11. Suzuki H, Fukushima M, Usami M, et al. Factors responsible for development from normal glucose tolerance to isolated post-challenge hyperglycemia. Diabetes Care 2003; 26: 1211-1215.
12. Fukushima M, Usami M, Ikeda M, et al. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism 2004; 53: 831-835.
13. Mitsui R, Fukushima M, Nishi Y, et al. Factors responsible for deteriorating glucose tolerance in newly diagnosed type 2 diabetes in Japanese men. Metabolism 2006; 55: 53-58.
14. Nishi Y, Fukushima M, Suzuki H, et al. Insulin secretion and insulin sensitivity in Japanese subjects with impaired fasting glucose and isolated fasting hyperglycemia. Diabetes Res Clin Pract 2005; 70: 46-52.
15. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039-1057.
16. Taniguchi A, Fukushima M, Sakai M, et al. Remnant-like particle cholesterol, triglycerides, and insulin resistance in non-obese Japanese type 2 diabetic patients. Diabetes Care 2000; 23: 1766-1769.
17. Seino Y, Nanjo K, Tajima N, et al.; The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 2010; 1: 212-228.
18. Seino Y, Ikeda M, Yawata M, et al. The insulinogenic index in secondary diabetes. Horm Metab Res 1975; 7: 107-115.
19. Matsuda M, Defronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euroglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470.
20. Yokota K, Fukushima M, Takahashi Y, et al. Insulin secretion and computed tomography values of pancreas in the early stage of the development of diabetes. J Diabetes Invest 2012; 3: 371-376.
21. Qiao Q, Tuomilehto J, Balkau B, et al.; DECODE Study Group. Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age? Diabet Med 2005; 22: 1476-1481.
22. Szoke E, Shrayyef MZ, Messing S, et al. Effect of Aging on glucose homeostasis: accelerated deterioration of β-cell function in individuals with impaired glucose tolerance. Diabetes Care 2008; 31: 539-543.
23. Bando Y, Ushiogi Y, Okafuji K, et al. The relationship of fasting plasma glucose values and other variables to 2-h postload plasma glucose in Japanese subjects. Diabetes Care 2001; 24: 1156-1160.
24. Taniguchi A, Fukushima M, Sakai M, et al. Effects of bezafibrate on insulin sensitivity and insulin secretion in non-obese Japanese type 2 diabetic patients. Metabolism 2001; 50: 477-480.
25. Taniguchi A, Fukushima M, Sakai M, et al. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients. Metabolism 2000; 49: 1001-1005.
26. Teramoto T, Shirai K, Daida H, et al. Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study. Cardiovasc Diabetol 2012; 11: 29.
27. Fukushima M, Suzuki H, Seino Y. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res Clin Pract 2004; 66S: 37-43.
28. Oka R, Yagi K, Sakurai M, et al. Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese. Endocr J 2012; 59: 55-64.
29. Rhee SY, Woo JT, Chon S, et al. Characteristics of insulin resistance and insulin secretory capacity in Korean subjects with IFG and IGT. Diabetes Res Clin Pract 2010; 89: 250-255.
30. Qian L, Xu L, Wang X, et al. Early insulin secretion failure leads to diabetes in Chinese subjects with impaired glucose regulation. Diabetes Metab Res Rev 2009; 25: 144-149.
31. Stancáková A, Javorský M, Kuulasmaa T, et al. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6, 414 Finnish men. Diabetes 2009; 58: 1212-1221.
32. Festa A, D'Agostino R Jr, Hanley AJ, et al. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 2004; 53: 1549-1555.
33. Carnevale SG, Rossi A, Sainaghi PP, et al. The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. Diabetes Care 2003; 26: 1333-1337.